Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Intersect ENT revenue decreased from $109.1 million in 2019 to $80.6 million in 2020, a (26.2%) decrease.

Annual Revenue ($)

Intersect ENT revenue was $80.55 m in FY, 2020 which is a (26.2%) year over year decrease from the previous period.

Quarterly Revenue ($)

FY, 2018FY, 2019FY, 2020
Revenue$108.47 m$109.14 m$80.55 m
Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021
Revenue$26.67 m$26.66 m$24.06 m$19.83 m$9.78 m$22.72 m$24.33 m$27.35 m

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Intersect ENT revenue breakdown by business segment: 92.3% from PROPEL family of products, 6.6% from SINUVA and 1.1% from Other

Q2, 2021Q1, 2021FY, 2020Q3, 2020Q2, 2020Q1, 2020FY, 2019Q3, 2019Q2, 2019
PROPEL family of products$23.06 m$20.44 m$74.34 m$21.05 m$9.48 m$19.09 m$104.66 m$22.96 m$25.56 m
SINUVA$2.69 m$2.44 m$5.32 m$1.67 m$299 k$736 k$4.49 m$1.09 m$1.1 m
VenSure, CUBE, and accessories$1.6 m$1.45 m$904 k

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu